dextrothyroxine has been researched along with Kahler Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Gao, Q; Huang, J; Li, L; Li, Q; Lin, Z; Liu, X; Luo, H; Niu, T; Wang, F; Wang, X; Wen, J; Zhai, X; Zhang, L; Zhang, Y; Zheng, Y | 1 |
| Conger, N; Glenn, K; Lindholm, DA; Meis, G; Watts, L | 1 |
| Driniaev, VA; Korystov, IuN; Krugliak, EB; Kublik, LN; Levitman, MKh; Mosin, VA; Narimanov, AA; Shaposhnikova, VV; Sterlina, TS; Viktorov, AV | 1 |
3 other study(ies) available for dextrothyroxine and Kahler Disease
| Article | Year |
|---|---|
Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Disease Models, Animal; Humans; Ivermectin; Mice; Multiple Myeloma; Proteasome Endopeptidase Complex; Proteasome Inhibitors | 2023 |
Case Report: A Case of Recurrent
Topics: Aged; Animals; Antibodies, Helminth; Antigens, Helminth; Colitis; Humans; Intestines; Ivermectin; Male; Multiple Myeloma; Strongyloides stercoralis; Strongyloidiasis | 2017 |
[Cytotoxic and cytostatic effect of avermectines on tumor cells in vitro].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cell Division; Humans; Ivermectin; Laryngeal Neoplasms; Mice; Multiple Myeloma; Neoplasms, Glandular and Epithelial; Tumor Cells, Cultured | 2000 |